Administration of recombinant factor VIIa for the management of massive bleeding due to uterine atonia in the post-placental period

Saved in:
Bibliographic Details
Published inActa obstetricia et gynecologica Scandinavica Vol. 84; no. 4; pp. 402 - 403
Main Authors Tanchev, Stoyan, Platikanov, Viliyan, Karadimov, Dimitar
Format Journal Article
LanguageEnglish
Published Oxford, UK; Malden, USA Munksgaard International Publishers 01.04.2005
Taylor & Francis
Subjects
Biological and medical sciences
bleeding
Factor VII - administration & dosage
Factor VII - therapeutic use
Factor VIIa
Female
Gynecology. Andrology. Obstetrics
Hemostatics - administration & dosage
Hemostatics - therapeutic use
Humans
Injections, Intravenous
Medical sciences
NovoSeven
Postpartum Hemorrhage - drug therapy
Postpartum Hemorrhage - etiology
Pregnancy
Recombinant Proteins - administration & dosage
Recombinant Proteins - therapeutic use
Shock, Hemorrhagic - drug therapy
Shock, Hemorrhagic - etiology
urine atonia
Uterine Inertia - complications
Urine
bleeding
Serine endopeptidases
Fetal membrane
Enzyme
Gynecology
Atonia
Hemorrhage
Obstetrics
urine atonia
Peptidases
Clinical management
Placenta
Treatment
Uterus
NovoSeven
Female genital system
Hydrolases
Recombinant protein
Coagulation Factor VIIa
Online AccessGet full text

Cover

More Information
Bibliography:ArticleID:AOG596
istex:31B6221CCEE6334AC38ABE02BDCC0351C0307A93
ark:/67375/WNG-4RBGWXDS-7
ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0001-6349
1600-0412
DOI:10.1111/j.0001-6349.2005.00596.x